Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Flt3-Itd Compared With Dnmt3a R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study; [Allojenik Hematopoetik Kok Hucre Nakli Sonrasi Yetiskin Akut Myeloid Losemi Hastalarinda, Flt3-Itd, Dnmt3a R882 Mutasyonu Ile Karsilastirildiginda Daha Guclu Bir Bagimsiz Kotu Prognostik Faktordur: Retrospektif Kohort Calismasi]
Maryam Barkhordar
Maryam Barkhordar

Assistant Professor of Hematology & Oncology

Shariati Hospital

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

All Documents
1. Age-Related Considerations in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia: A 10-Year Retrospective Study, International Journal of Hematology-Oncology and Stem Cell Research (2025)
2. Evaluating the Safety and Feasibility of Allogeneic Nk Cell Infusion in High-Risk Lymphoma Patients Post-Autologous Stem Cell Transplantation, Discover Oncology (2025)
3. Genicular Artery Embolization Using Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Prospective Study, Journal of Vascular and Interventional Radiology (2025)
4. Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia Patients Who Underwent Myeloablative Tbi-Free Conditioning Regimen, Leukemia and Lymphoma (2025)
5. Plasma-Circulating Mir-638, Mir-6511B-5P, Mir-3613-5P, Mir-455-3P, Mir-5787, and Mir-548A-3P As Noninvasive Biomarkers of Immune Reconstitution Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients, Transplant Immunology (2025)
6. Predictive Modeling of Outcomes in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Machine Learning Techniques, Leukemia Research (2025)
7. Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma, Advanced Pharmaceutical Bulletin (2025)
8. Safety and Feasibility of Blockade of Nk Group-2 Member-A Receptor in Natural Killer Cells Combined With Cetuximab Antibody in Patients With Advanced Gastric Adenocarcinoma, Advanced Pharmaceutical Bulletin (2025)
9. Stem Cell Transplantation Cost in Iran, BMC Health Services Research (2025)
10. Car-Nk Cells As Promising Immune Therapeutics: Platforms and Current Progress, International Journal of Cancer Management (2024)
11. Cell Therapy Using Anti-Nkg2a Pretreated Natural Killer Cells in Patients With Hepatocellular Carcinoma, Advanced Pharmaceutical Bulletin (2024)
12. Circulating Micrornas As the Achilles Forte of Diagnostics and Prognostics in Acute Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation, Gene Reports (2024)
13. Corrigendum: Determining the Predictive Impact of Donor Parity on the Outcomes of Human Leukocyte Antigen Matched Hematopoietic Stem Cell Transplants: A Retrospective, Single-Center Study(Front. Oncol., (2024), 14, (1339605), 10.3389/Fonc.2024.1339605), Frontiers in Oncology (2024)
14. Determining the Predictive Impact of Donor Parity on the Outcomes of Human Leukocyte Antigen Matched Hematopoietic Stem Cell Transplants: A Retrospective, Single-Center Study, Frontiers in Oncology (2024)
15. Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma Mir-638, Mir-6511B-5P, Mir-3613-5P, Mir-455-3P, Mir-5787, and Mir-548A-3P As Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation, Clinical Transplantation (2024)
16. Dose-Dependent Effect of Megestrol Acetate Supplementation in Cancer Patients With Anorexia–Cachexia Syndrome: A Meta-Analysis, Journal of Cachexia, Sarcopenia and Muscle (2024)
17. Dose-Dependent Effect of Megestrol Acetate Supplementation in Cancer Patients With Anorexia–Cachexia Syndrome: A Meta-Analysis, Journal of Cachexia, Sarcopenia and Muscle (2024)
18. Efficacy and Safety of Adoptive T-Cell Therapy in Treating Cytomegalovirus Infections Post-Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis, Reviews in Medical Virology (2024)
19. Hsct at a Glance, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
20. Immunologic Responses to the Third and Fourth Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccines in Cell Therapy Recipients: A Systematic Review and Meta-Analysis, Virology Journal (2024)
21. Rehabilitation in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
22. The Effect of Oral Nutrition Supplement (Ons) on the Nutritional and Clinical Status of Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: Study Protocol for a Randomized Controlled Clinical Trial, BMC Nutrition (2024)
23. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)
24. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)
25. Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience, International Journal of Hematology-Oncology and Stem Cell Research (2023)
26. Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-Term Follow-Up, Cell Transplantation (2023)
27. Comparison of Three Malnutrition Screening Tools Prior to Allogeneic Hematopoietic Stem-Cell Transplantation, Frontiers in Nutrition (2023)
28. Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (Rbd)-Tetanus Toxoid (Tt) Conjugated Sars-Cov-2 Vaccine (Pastocovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; a Prospective, Open-Label Clinical Trial, Vaccines (2023)
29. Homologous Versus Heterologous Prime-Boost Covid-19 Vaccination in Autologous Hematopoietic Stem Cell Transplantation Recipients: A Blinded Randomized Controlled Trial, Frontiers in Immunology (2023)
30. Phase I Non-Randomized Clinical Trial of Allogeneic Natural Killer Cells Infusion in Acute Myeloid Leukemia Patients, BMC Cancer (2023)
31. The Impact of Malnutrition on Mortality and Complications of Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia, Clinical Nutrition (2023)
32. Three Doses of a Recombinant Conjugated Sars-Cov-2 Vaccine Early After Allogeneic Hematopoietic Stem Cell Transplantation: Predicting Indicators of a High Serologic Response—A Prospective, Single-Arm Study, Frontiers in Immunology (2023)
33. Modified Combination of Anti-Thymocyte Globulin (Atg) and Post-Transplant Cyclophosphamide (Ptcy) As Compared With Standard Atg Protocol in Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia, Frontiers in Immunology (2022)
34. Outcomes of Haploidentical Peripheral Stem Cell Transplantation With Combination of Post-Transplant Cyclophosphamide (Ptcy) and Anti-Thymocyte Globulin (Atg) Compared to Unrelated Donor Transplantation in Acute Myeloid Leukemia: A Retrospective 10-Year Experience, Leukemia Research (2022)
35. Peripheral Blood Stem Cell Transplantation From Haploidentical and Unrelated Versus Related Donors for Acute Leukemia in Children, Adolescents and Young Adults (Caya): A Competing Risk Analysis, Cellular Therapy and Transplantation (2022)
36. Wharton's Jelly-Mesenchymal Stem Cells Treatment for Severe Covid 19 Patients: 1-Year Follow-Up, Gene Reports (2022)
37. Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare Between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation, International Journal of Hematology-Oncology and Stem Cell Research (2021)
38. Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Covid-19 Pandemic: An Iranian Consensus, Mediterranean Journal of Hematology and Infectious Diseases (2020)
39. Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial, International Journal of Hematology-Oncology and Stem Cell Research (2018)